Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
34,003,932
-
Shares change
-
+7,207,844
-
Total reported value, excl. options
-
$319,613,212
-
Value change
-
+$76,425,883
-
Put/Call ratio
-
20%
-
Number of buys
-
69
-
Number of sells
-
-45
-
Price
-
$9.40
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q4 2022
155 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q4 2022.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34,003,932 shares
of 113,177,462 outstanding shares and own 30% of the company stock.
Largest 10 shareholders include MILLENNIUM MANAGEMENT LLC (4,382,500 shares), VANGUARD GROUP INC (3,325,671 shares), Boxer Capital, LLC (1,500,000 shares), BlackRock Inc. (1,346,013 shares), Laurion Capital Management LP (1,299,000 shares), GREAT POINT PARTNERS LLC (1,295,034 shares), TWO SIGMA INVESTMENTS, LP (1,265,188 shares), Point72 Asset Management, L.P. (1,105,600 shares), D. E. Shaw & Co., Inc. (951,240 shares), and RENAISSANCE TECHNOLOGIES LLC (950,600 shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.